In our latest blog, Maria Visser and Martina Micaletto discuss the subjectivity of instruments used to measure #atopicdermatitis severity, the importance of data accuracy, and how different assessment methods can impact trial outcomes. Read more: https://hubs.li/Q02FPf490 #ClinicalTrials #DermatologyResearch
Signant Health
Pharmaceutical Manufacturing
Blue Bell, Pennsylvania 109,153 followers
The Evidence Generation Company
About us
Signant Health is the evidence generation company. We are focused on leveraging software, deep therapeutic and scientific knowledge, and operational expertise to consistently capture, aggregate, and reveal quality evidence for clinical studies across traditional, virtual, and hybrid trial models. For more than 25 years, over 600 sponsors and CROs of all sizes – including all Top 20 pharma – have trusted Signant solutions for remote and site-based eCOA, EDC, eConsent, RTSM, supply chain management, and data quality analytics. Learn more at www.signanthealth.com.
- Website
-
http://www.signanthealth.com
External link for Signant Health
- Industry
- Pharmaceutical Manufacturing
- Company size
- 1,001-5,000 employees
- Headquarters
- Blue Bell, Pennsylvania
- Type
- Privately Held
- Specialties
- clinical trial software, eCOA, eConsent, IRT, Clinical Supply Optimization, Patient Engagement, Rater Training, Data Quality, Analytics, Scientific Consulting, and Clinical Consulting
Locations
Employees at Signant Health
-
John Hughes
Business Development and Operations Executive - enabling revenue growth through strategy, process, technology and culture.
-
Markku Lukkarinen
Senior UX Designer at Weasel Software
-
Joanne Kondan
Finance and Operations Leader, Specializing in Operational Effectiveness
-
Konstantin Kondakov
SRE / CloudOps / DevOps / TechOps / WebOps "hands-on"senior manager
Updates
-
Discover a simpler #clinicaltrial experience without compromising quality or functionality with Signant SmartSignals® Unified Platform. Say goodbye to managing multiple systems and vendors for each trial. Learn more: https://hubs.li/Q02Ffn7m0
See what sponsors and CROs have been asking for
https://www.signanthealth.com
-
In this podcast, Signant's Bill Byrom PhD, speaks with Julian Minett, CEO of Spencer Group, about the use of #AI and #MachineLearning in clinical #drugdevelopment. While covering a breadth of topics and application areas, one promising area they examine is how AI can be a useful tool in COA development and implementation, using case study illustrations. Listen now: https://hubs.li/Q02F3kVd0
The Future of eCOA & AI with Signant Health’s Bill Byrom - Spencer Group
https://spencergroup.com
-
At #AAIC2024, discover how our renowned #alzheimers experts and proven endpoint quality solutions continue to facilitate success in #clinicaltrials. Meet our team and get resources: https://hubs.li/Q02F0wLF0 Dawie Wessels, Maria Kerwin, Linda Berkowitz, Sandra Marticio, JENNIFER BETZ, Matthew Cordaro, MBA, Brian Mcallister, Alex Brooks, david miller
Pioneering Alzheimer's trial solutions to support research breakthroughs
hub.signanthealth.com
-
Navigating the complexities of #RTSM can be challenging for sponsors and service providers. Our latest blog post by James Stringer highlights best practices and common pitfalls to help you optimize your #clinicaltrials. Learn more: https://hubs.li/Q02DYJ3b0
Drive continuous improvement, ensure optimal outcomes for every study
https://www.signanthealth.com
-
Calling all CROs: Looking to stay competitive and win more business? 📈 You won't want to miss insights from our latest eBook. Discover how #eClinical partnerships can help you differentiate and deliver successful trials for sponsors. Get your copy now: https://hubs.ly/Q02DpBhd0
Gain insights and practical strategies developed by industry experts
discover.signanthealth.com
-
🚀Seeking a faster #eCOA solution? Discover TrialMax® – the industry's most reliable and feature-rich platform, now enhanced with intelligent automations for 33% faster study launches. Learn more: https://hubs.li/Q02DcdhZ0
-
In this latest installment of our Science & Medicine blog series, Helen Brooker and Pascal Goetghebeur examine how cognitive testing in Phase I #clinicaltrials is crucial for understanding a compound's impact on patient outcomes and overall drug safety/tolerability: https://hubs.li/Q02D3kJv0
The benefits of detecting cognitive function changes early in drug development
https://www.signanthealth.com
-
June is #PTSDAwarenessMonth and it's crucial to spread the word that treatments can significantly improve quality of life. Our expertise and innovative technology help study teams recognize, diagnose, and assess changes in PTSD patients. Learn more: https://hubs.li/Q02CP7_w0
We’re dedicated to supporting PTSD research and treatment
hub.signanthealth.com
-
Focus on what truly matters in #clinicalresearch with Signant Biotech. Our team of scientific, regulatory, operational, and technical experts are here to provide you with tailored solutions and unparalleled expertise to help you achieve your goals. Learn more: https://hubs.li/Q02CGDn_0
Discover how our comprehensive eClinical solutions can ensure you meet milestones
https://www.signanthealth.com